title: Impact of therapy on the development of second malignancies in essential thrombocythemia and polycythemia vera: Are we comfortable about this?
authors.affiliation: a Department of Diagnostic , Clinical, and Public Health Medicine, University of Modena and Reggio Emilia , Modena , Italy.
authors.forename: Luigi
authors.initials: L
authors.lastname: Marcheselli
authors.affiliation: b Department of Hematology , Hadassah University, Hospital and Hebrew University Medical School , Jeruslaem , Israel.
authors.forename: Aaron
authors.initials: A
authors.lastname: Polliack
authors.affiliation: c Hematology Unit, Bnai-Zion Medical Center , Haifa , Israel.|d Rappaport Faculty of Medicine, Technion, Institute of Technology , Haifa , Israel.
authors.forename: Tamar
authors.initials: T
authors.lastname: Tadmor
mesh_terms: D006801:Humans; D016609:Neoplasms, Second Primary; D010976:Platelet Count; D011087:Polycythemia Vera; D013920:Thrombocythemia, Essential; D013922:Thrombocytosis